The liver in transforming growth factor-beta-1 (TGF-β1) null mutant mice

Ultrastructural Pathology

Volumn 20, Issue 5, 1996, Pages 477-490

  Williams, A Olufemi ^a   Knapton, Alan D ^a   Geiser, Andrew ^a   Letterio, John J ^a   Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Golgi; Inclusions; Intracytoplasmic canaliculi; Liver; Mice; Mitochondria; Phenotype; TFG 1

Indexed keywords

RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GOLGI COMPLEX; INFLAMMATION; LIVER; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0006010813     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129609016352     Document Type: Article

References (46)

1. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol. 1990;6:597-641.
2. Roberts AB, Sporn MB. The transforming growth factors-betas. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors. New York: Springer; 1990: 419-472.
3. Kingsley DM. The TGFβ superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev. 1994;8:133-146.
4. Heine UI, Burmeister JK, Flanders KC, et al. Localization of transforming growth factor-β1 in mitochondria of murine heart and liver. Cell Regul. 1991;2:467-477.
5. Florini JR, Roberts AB, Ewton DZ, Falen SL, Flanders KC, Sporn MB. Transforming growth factor-beta: a very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J Biol Chem. 1986;261:16509-16513.
6. Massague J, Cheifetz S, Endo T, Nadal-Ginard B. Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA. 1986;83:8206-8210.
7. Olson EN, Sternberg E, Hu JS, Spizz G, Wilcox C. Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol. 1986;103:1799-1805.
8. Seyedin SM, Thomas TC, Thompson AY, Rosen DM, Piez KA. Purification and characterization of two cartilage inducing factors from bovine demineralized bone. Proc Natl Acad Sci USA. 1985;82:2267-2271.
9. Ignotz RA, Massague J. Type-β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc Natl Acad Sci USA. 1985;82:8530-8534.
10. Centrella M, McCarthy TL, Canalis E. Skeletal tissue and transforming growth factor-β. FASEB J. 1988;2:3066-3073.
11. Tucker RF, Branum EL, Shipley GD, Ryan RJ, Moses HL. Growth inhibitor from BSC-1 cells is closely related to the platelet type-β transforming growth factor. Science. 1984; 226:705-707.
12. Moses HL, Tucker RF, Leof EB, Coffey RJ Jr, Haper J, Shipley GD. Type-β transforming growth factor is a growth stimulator and growth inhibitor. In: Feramisco J, Ozanne B, Stiles C, eds. Cancer Cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1985:65-75.
13. Boyd FT, Massague J. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53 kD membrane protein. J Biol Chem. 1989;264: 2272-2278.
14. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-B receptor in colon cancer cells with microsatellite instability. Science. 1995;268:1336-1338.
15. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transforming growth factor-β1 null mice. Science. 1994;264:1936-1938.
16. Shull MM, Ormsby I, Kier AB, et al. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992; 359:693-699.
17. Erickson HP. Gene knockouts of src, transforming growth factor-β1, and tenascin suggest superfluous, nonfunctional expression of proteins. J Æ Biol. 1993;120:1079-1081.
18. Miller DA, Pelton RW, Deryn R, Moses HL. Transforming growth factor-β1: a family of growth regulatory peptides. Ann N Y Acad Sci. 1990;593:208-217.
19. Sambrook J, Fritch EF, Maniatis T. Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
20. Flanders KC, Thompson NL, Cissel DS, et al. Transforming growth factor-β1 histochemical localization with antibodies to different epitopes. J Cell Biol. 1989;108:653-660.
21. Lechner JF, LaVeck MA. A serum free method for culturing normal human bronchial epithelial cells at clonal density. J Tiss Cult Methods. 1985;9:43-48.
22. Ghadially FN. Intracytoplasmic lumina. In: Ultrastructural Pathology of the Cell and Matrix, 2d ed. Butterworths: London; 1982.
23. Ghadially FH. Diagnostic Electronmicroscopy of Tumors, 2d ed. Butterworths: London; 1985.
24. Koga A. Morphogenesis of intrahepatic bile ducts in the human fetus: light and electron microscopic study. Z Anat Entwickl-Gesch. 1971;135:156-184.
25. Harris M, Vasudev KS, Anfield C, Wells S. Mucin producing carcinomas of the breast: ultrastructural observations. Histopathology. 1978;2:177-188.
26. Kern WH, Dermer GB. The cytopathology of hyperplastic and neoplastic mammary duct epithelium: cytologic and ultrastructural studies. Acta Cytol. 1972;16:120-125.
27. Archer F, Omar M. The fine structure of fibroadenoma of the human breast. J Pathol. 1969;99:113-117.
28. Carter D, Yardley JH, Shelley WM. Lobular carcinoma of the breast: an ultrastructural comparison with certain duct carcinomas and benign lesions. Johns Hopkins Med J. 1969;125:25-43.
29. Kulkarni AB, Huh C-G, Becker D, et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993;90:770-774.
30. Kulkarni AB, Ward JM, Yaswen L, et al. Transforming growth factor-β null mice: an animal model for inflammatory disorders. Am J Pathol. 1995;146:264-275.
31. Heine UI, Munoz EF, Flanders KC, et al. Role of transforming growth factor-β in the development of the mouse embryo. J Cell Biol. 1987;105:2861-2876.
32. Bruguera M, Bertran A, Bombi JA, Rodes J. Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease. Gastroenterology. 1977;73:1383-1387.
33. Lefkowitch JH, Arborgh BAM, Scheuer PJ. Oxyphilic granular hepatocytes: mitochondrion-rich liver cells in hepatic disease. Am J Clin Pathol. 1980;74:432-441.
34. Fleming KA, McGee JO'D. Review article: alcohol induced liver disease. J. Clin Pathol. 1984;377:721-733.
35. Desmet VJ. Alcoholic liver disease: histological features and evolution. Acta Med Scand. 1985;703:111-126.
36. Uchida T, Kronborg I, Peters RL. Giant mitochondria in alcoholic liver diseases: their identification frequency and pathologic significance. Liver. 1984;4:29-38.
37. Mellman I, Simons K. The Golgi complex: in vitro veritas? Cell. 1992;68:829-840.
38. Rothman JE, Orci L. Molecular dissection of the secretory pathway. Nature. 1992;355:409-415.
39. Vendemiale G, Guerrieri F, Grattagliano I, Didonna D, Muolo L, Altomare E. Mitochondrial oxidative phosphorylation and intracellular glutathione compartmentation during rat liver regeneration. Hepatology. 1995;21:1450-1454.
40. Antonetti DA, Reynet C, Kahn RC. Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invst. 1995;95:1383-1388.
41. Ericson LE. Intracellular lumens in thyroid follicle cells of thyroxine-treated rats. J Ultrastruct Res. 1979;69:297-305.
42. Remy L, Michel-Bechet M, Cataldo C, Bottini J, Hovseplan S, Fayet G. The role of intracellular lumina in thyroid cells for follicle morphogenesis in vitro. J Ultrastruct Res. 1977; 61:243-248.
43. Horiuch R, Uchida T, Shikata T. A newly recognized hepatic inclusion body, "ring body": significance of its occurrence. Acta Hepatol Jpn. 1986;27:945-952.
44. Ozello L. Ultrastructure of human mammary carcinoma cells in vivo and in vitro. J Natl Cancer Inst. 1972;48:1043-1050.
45. Sobrinho-Simoes M, Johannessen JV, Gould VE. The diagnostic significance of intracytoplasmic lumina in metastatic neoplasms. Ultrastruct Pathol. 1981;2:37-42.
46. Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol. 1992;119: 1017-1021.